Karen E Stewart1, Robert P Hart2, Douglas P Gibson2, Robert A Fisher3. 1. Department of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA. Electronic address: Kstewart2@mcvh-vcu.edu. 2. Department of Psychiatry, Virginia Commonwealth University, Richmond, VA. 3. Department of Surgery, Virginia Commonwealth University, Richmond, VA.
Abstract
BACKGROUND: End-stage liver disease is associated with diminished quality of life (QOL). Numerous physical and psychosocial problems that affect QOL are common in those undergoing evaluation for liver transplantation. OBJECTIVE: Identifying which of these challenges are most closely associated with QOL would be helpful in developing priority targets for evidence-based interventions specific to those undergoing transplant evaluation. METHOD: A total of 108 adults undergoing psychologic assessment for liver transplant completed clinical interview, neuropsychologic testing, and self-report inventories of depression, anxiety, cognitive appraisal characteristics, support resources, and QOL. RESULTS: Multiple regression analyses revealed that while emotional symptoms (anxiety and depression) were primarily associated with mental QOL, illness apprehension was the only variable uniquely associated with physical QOL after accounting for severity of liver disease, cognitive status, emotional symptoms, and support resources. CONCLUSION: Findings suggest that psychosocial interventions prioritizing reduction of illness-related fear and symptoms of anxiety/depression would likely have the greatest effect on QOL in persons with end-stage liver disease awaiting transplantation.
BACKGROUND:End-stage liver disease is associated with diminished quality of life (QOL). Numerous physical and psychosocial problems that affect QOL are common in those undergoing evaluation for liver transplantation. OBJECTIVE: Identifying which of these challenges are most closely associated with QOL would be helpful in developing priority targets for evidence-based interventions specific to those undergoing transplant evaluation. METHOD: A total of 108 adults undergoing psychologic assessment for liver transplant completed clinical interview, neuropsychologic testing, and self-report inventories of depression, anxiety, cognitive appraisal characteristics, support resources, and QOL. RESULTS: Multiple regression analyses revealed that while emotional symptoms (anxiety and depression) were primarily associated with mental QOL, illness apprehension was the only variable uniquely associated with physical QOL after accounting for severity of liver disease, cognitive status, emotional symptoms, and support resources. CONCLUSION: Findings suggest that psychosocial interventions prioritizing reduction of illness-related fear and symptoms of anxiety/depression would likely have the greatest effect on QOL in persons with end-stage liver disease awaiting transplantation.
Authors: M A Dew; G E Switzer; J M Goycoolea; A S Allen; A DiMartini; R L Kormos; B P Griffith Journal: Transplantation Date: 1997-11-15 Impact factor: 4.939
Authors: Sammy Saab; Ayman B Ibrahim; Alexander Shpaner; Zobair M Younossi; Cindy Lee; Francisco Durazo; Steven Han; Karl Esrason; Victor Wu; Jonathan Hiatt; Douglas G Farmer; R Mark Ghobrial; Curtis Holt; Hasan Yersiz; Leonard I Goldstein; Myron J Tong; Ronald W Busuttil Journal: Liver Transpl Date: 2005-02 Impact factor: 5.799
Authors: Sheila G Jowsey; Susanne M Cutshall; Robert C Colligan; Susanna R Stevens; Walter K Kremers; Adriana R Vasquez; Brooks S Edwards; Richard C Daly; Christopher G A McGregor Journal: Prog Transplant Date: 2012-03 Impact factor: 1.187
Authors: Emily M Rosenberger; Mary Amanda Dew; Andrea F DiMartini; Annette J DeVito Dabbs; Roger D Yusen Journal: Thorac Surg Clin Date: 2012-11 Impact factor: 1.750
Authors: Lissi Hansen; Karen S Lyons; Nathan F Dieckmann; Michael F Chang; Shirin Hiatt; Emma Solanki; Christopher S Lee Journal: Res Nurs Health Date: 2017-06-30 Impact factor: 2.228
Authors: Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon Journal: J Pain Symptom Manage Date: 2018-03-08 Impact factor: 3.612
Authors: Sandhya K Mudumbi; Claire E Bourgeois; Nicholas A Hoppman; Catherine H Smith; Manisha Verma; Marie A Bakitas; Cynthia J Brown; Alayne D Markland Journal: J Palliat Med Date: 2018-04-26 Impact factor: 2.947